NEW YORK/LONDON -- The novel coronavirus has left companies grappling with difficult questions about how much to tell investors about risks to earnings and how to handle cases in the workplace.
Coronavirus
Companies fret over how much to disclose on coronavirus risks
Employee infections force tough decisions on public reports
